Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compartment model of prenalterol.

G Klein, A Wirtzfeld, G Bozler

    Acta Medica Scandinavica. Supplementum
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans.

    The Journal of pharmacy and pharmacology·2002
    Same author

    Multicenter registry to evaluate the efficacy of the NIROYAL stent in de novo or restenotic coronary stenosis.

    The Journal of invasive cardiology·2000
    Same author

    Influence of neutron activation factors on matrix tablets for site specific delivery to the colon.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2000
    Same author

    Development of pectin matrix tablets for colonic delivery of model drug ropivacaine.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2000
    Same author

    The influence of frusemide formulation on diuretic effect and efficiency.

    British journal of clinical pharmacology·1999
    Same author

    Influence of neutron activation factors on the physico-chemical properties of suppositories and their excipients.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·1999

    This study validated pharmacokinetic models for prenalterol using the TOPFIT program. The validated model accurately predicted plasma concentrations after repeated intravenous dosing in healthy subjects.

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism and Disposition

    Background:

    • Previous studies characterized prenalterol plasma concentration with a short distribution (alpha) phase (8 min half-life) and an elimination (beta) phase (2 hr half-life).
    • Understanding drug kinetics is crucial for optimizing therapeutic efficacy and safety.

    Purpose of the Study:

    • To validate pharmacokinetic data of intravenous single-dose prenalterol using the TOPFIT computer program.
    • To assess the predictive accuracy of kinetic models for plasma concentrations following repetitive prenalterol administration.

    Main Methods:

    • Analysis of prenalterol plasma concentration data from intravenous single-dose administration in healthy subjects.
    • Utilized the TOPFIT computer program to evaluate different compartment models.
    • Tested the predictive power of the selected kinetic model against repetitive dosing data.

    Related Experiment Videos

    Main Results:

    • The TOPFIT program was employed to analyze prenalterol's pharmacokinetic profile.
    • Different compartment models were assessed for their ability to describe the observed data.
    • The chosen kinetic model demonstrated predictive capability for plasma concentrations during repetitive dosing.

    Conclusions:

    • Pharmacokinetic data for prenalterol can be reliably analyzed using the TOPFIT program.
    • A validated kinetic model accurately predicts prenalterol plasma concentrations after repeated intravenous administration.
    • This supports the use of pharmacokinetic modeling for optimizing prenalterol dosing regimens.